|
26 Jun 2007 |
Bentley Reports Positive Results with Nasulin(TM) Intranasal Insulin Spray at the American Diabetes Association Meeting
|
|
25 Jun 2007 |
BYETTA(R) Study Showed Comparable Blood Glucose Control to Insulin
|
|
24 Jun 2007 |
SYMLIN(R) Used in Conjunction with Basal Insulin in Patients with Type 2 Diabetes
|
|
24 Jun 2007 |
BYETTA(R) Treatment for Three and a Half Years Associated with Reductions in Cardiovascular Risk Factors in People with Type 2 Diabetes
|
|
22 Jun 2007 |
Liraglutide provides significantly better glucose control than insulin glargine in phase 3 study
|
|
22 Jun 2007 |
Liraglutide provides significantly better glucose control than insulin glargine in phase 3 study
|
|
21 Jun 2007 |
Shire in-licenses JUVISTA(R) (human TGFβ3) from Renovo
|
|
21 Jun 2007 |
Modigene Announces Successful Completion of Pharmacokinetic & Pharmacodynamic Pre-Clinical Experiments for Proprietary Long-Acting Human Growth Hormone, Long-acting Interferon Beta and Long-acting Erythropoietin
|
|
21 Jun 2007 |
King Pharmaceuticals Announces FDA Approval of Epistaxis Kit for THROMBIN-JMI(R)
|
|
20 Jun 2007 |
ZymoGenetics Establishes Global Collaboration With Bayer HealthCare for Development and Commercialization of Recombinant Human Thrombin
|
|
20 Jun 2007 |
Merck Serono and Ambrx to collaborate on development of next generation growth hormone products
|
|
20 Jun 2007 |
Nuvelo Announces Publication of Phase 2 rNAPc2 Study Results in Journal of American College of Cardiology
|
|
20 Jun 2007 |
ConjuChem Biotechnologies Reports PC-DAC(TM):Exendin-4 Albumin Conjugate Data Presented at American Diabetes Association Annual Meeting
|
|
19 Jun 2007 |
Advanced Viral Research Corp. Announces Positive Preliminary Findings from Ongoing Phase II Dermatological Study
|
|
19 Jun 2007 |
Presentation of In Vivo HDL Kinetic Data at the European Atherosclerosis Society 76th Congress Demonstrates Activation of Reverse Cholesterol Transport by Pre-Beta HDL in Selectively Delipidated
|
|
16 Jun 2007 |
Novo Nordisk and Neose announce initiation of phase 1 clinical trial of long-acting factor VIIa
|
|
15 Jun 2007 |
Fabry Study Demonstrates Sustained, Long-Term Renal Stabilization After 54 Months
|
|
13 Jun 2007 |
IBPL Becomes Country's First Dedicated Biopharmaceutical Facility to Receive EU-GMP Certification
|
|
13 Jun 2007 |
Eurand Files NDA for Zentase(TM) for Exocrine Pancreatic Insufficiency
|
|
12 Jun 2007 |
Phase III clinical trial with 4-month long-acting formulation of triptorelin: Ipsen decides not to perform further administration
|
|
12 Jun 2007 |
Altus Pharmaceuticals Reacquires European Development and Commercialization Rights to ALTU-135
|
|
09 Jun 2007 |
Scios Announces Enrollment of First Patients in Ascend-HF
|
|
08 Jun 2007 |
Alkermes Announces Initiation of Phase I Clinical Study of AIR(R) Parathyroid Hormone
|
|
08 Jun 2007 |
Discovery Labs Initiates Phase 2 Clinical Trial in Children with Acute Respiratory Failure
|
|
08 Jun 2007 |
Human Genome sciences announces positive final results of Phase 2b trial of Albuferon(R)
|
